Next-Generation Bed Nets to Control Malaria in Côte d'Ivoire.

NEJM EvidOct 27, 2026 (epub)

Colette Sih, Serge B Assi, Edouard Dangbenon et al.

✦ AI-curated · Sources linked

In 30 seconds

This cluster-randomized clinical trial compared pyrethroid-only long-lasting insecticidal nets with piperonyl butoxide-pyrethroid (PBO-py) and chlorfenapyr-pyrethroid (CFP-py) nets in villages in Côte d'Ivoire. The primary outcome was malaria incidence over 12 months among children aged 6 months to 9 years. Mean incidence was 1.11 cases per child-year with pyrethroid-only nets, 0.84 with PBO-py nets, and 0.65 with CFP-py nets. Compared with control nets, incidence rate ratios were 0.72 for PBO-py and 0.57 for CFP-py.

Key findings

  • Mean malaria incidence was 1.11 cases per child-year with pyrethroid-only nets, 0.84 with PBO-py nets, and 0.65 with CFP-py nets.
  • PBO-py versus pyrethroid-only nets had an incidence rate ratio of 0.72 (95% confidence interval [CI], 0.52 to 0.99; P=0.045).
  • CFP-py versus pyrethroid-only nets had an incidence rate ratio of 0.57 (95% CI, 0.43 to 0.75; P<0.001).

Why it matters

In this trial, both next-generation net types were associated with lower malaria incidence in children than pyrethroid-only nets, with the larger reduction observed for CFP-py nets. These findings provide comparative evidence from West Africa, where the abstract notes that nets treated with multiple insecticides have been insufficiently evaluated.

What to keep in mind

The primary outcome covered only the year following net distribution and children aged 6 months to 9 years in clusters in Côte d'Ivoire; the abstract does not report outcomes beyond this population or period.

Source

Published in NEJM Evid. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Infectious Diseases

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.